Cardiac allograft vasculopathy and donor age affecting permanent pacemaker implantation after heart transplantation
Sign Up to like & getrecommendations! Published in 2022 at "ESC Heart Failure"
DOI: 10.1002/ehf2.13799
Abstract: The need for permanent pacemakers (PMs) after heart transplantation (HT) is increasing. The aim was to determine the influence of cardiac allograft vasculopathy (CAV), donor age, and other risk factors on PM implantations early and… read more here.
Keywords: donor age; cardiac allograft; allograft vasculopathy; heart ... See more keywords
Comparison of Angiographic Outcomes after Drug-eluting Stents and Bare-metal Stents in Patients with Cardiac Allograft Vasculopathy: A Metanalysis
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Cardiac Failure"
DOI: 10.1016/j.cardfail.2018.07.036
Abstract: Background Coronary Allograft Vasculopathy (CAV) is a major determinant of long term survival after cardiac transplantation and remains one of the leading causes of death after the first year of orthotopic heart transplantation (OHT). Percutaneous… read more here.
Keywords: drug eluting; eluting stents; analysis; bare metal ... See more keywords
Looking into the Future: Optical Coherence Tomography for the Assessment of Cardiac Allograft Vasculopathy
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Cardiac Failure"
DOI: 10.1016/j.cardfail.2019.07.330
Abstract: Introduction Current guidelines recommend coronary angiography with intravascular ultrasound (IVUS) as a screening and surveillance tool for the assessment of cardiac allograft vasculopathy (CAV). The role of optical coherence tomography (OCT) has not been thoroughly… read more here.
Keywords: optical coherence; allograft vasculopathy; assessment; cardiac allograft ... See more keywords
TCT-401 A Strategy of Percutaneous Coronary Intervention with Drug-Eluting Stents for the Treatment of Cardiac Allograft Vasculopathy May Normalize Survival
Sign Up to like & getrecommendations! Published in 2018 at "Journal of the American College of Cardiology"
DOI: 10.1016/j.jacc.2018.08.1560
Abstract: PCI for cardiac allograft vasculopathy (CAV) is associated with high revascularization rates but acceptable stent and lesion patency. Whether a strategy of PCI normalizes survival is not known. Pts who underwent PCI with 2nd gen… read more here.
Keywords: strategy; cardiac allograft; allograft vasculopathy;
Donor specific anti-HLA antibodies and cardiac allograft vasculopathy: A prospective study using highly automated 3-D optical coherence tomography analysis.
Sign Up to like & getrecommendations! Published in 2020 at "Transplant immunology"
DOI: 10.1016/j.trim.2020.101340
Abstract: INTRODUCTION Recent studies suggested potential positive correlations between HLA-specific antibodies and development of cardiac allograft vasculopathy (CAV). METHODS This prospective two-center study investigated early progression of CAV by coronary optical coherence tomography in 1 month… read more here.
Keywords: optical coherence; cardiac allograft; dsa; coherence tomography ... See more keywords
Paediatric heart transplantation recipients ≥7 years of age receiving donors with pre-existing coronary atherosclerosis showed progressive coronary artery disease.
Sign Up to like & getrecommendations! Published in 2021 at "Cardiology in the young"
DOI: 10.1017/s1047951121003784
Abstract: BACKGROUND This study aimed to determine the effect of donor-transmitted atherosclerosis on the late aggravation of cardiac allograft vasculopathy in paediatric heart recipients aged ≥7 years. METHODS In total, 48 patients were included and 23… read more here.
Keywords: allograft vasculopathy; atherosclerosis; cardiac allograft; transmitted atherosclerosis ... See more keywords
Factors associated with the cardiac allograft vasculopathy after heart transplantation
Sign Up to like & getrecommendations! Published in 2020 at "European Heart Journal"
DOI: 10.1093/ehjci/ehaa946.2697
Abstract: Cardiac allograft vasculopathy (CAV) is a major threat to long-term survival after heart transplantation (HT). The frequency of CAV is estimated to be 8% at 1 year after HT, 30% at the 5-year follow-up, and… read more here.
Keywords: heart; cardiac allograft; heart transplantation; cav ... See more keywords
Diagnostic and prognostic value of myocardial blood flow quantification as non-invasive indicator of cardiac allograft vasculopathy
Sign Up to like & getrecommendations! Published in 2018 at "European Heart Journal"
DOI: 10.1093/eurheartj/ehx683
Abstract: Aims Cardiac allograft vasculopathy (CAV) is a leading cause of death in orthotopic heart transplant (OHT) survivors. Effective non-invasive screening methods are needed. Our aim was to investigate the added diagnostic and prognostic value of… read more here.
Keywords: pet; cardiac allograft; value; non invasive ... See more keywords
The beginning at the end: non-invasive assessment of post-transplant coronary allograft vasculopathy at the microcirculatory level
Sign Up to like & getrecommendations! Published in 2018 at "European Heart Journal"
DOI: 10.1093/eurheartj/ehx738
Abstract: In the first year after orthotopic heart transplantation (OHT), acute cellular and/or humoral rejection is associated with coronary allograft vasculopathy (CAV) that can lead to graft failure. CAV is still an unsolved issue. In spite… read more here.
Keywords: dysfunction; year; coronary allograft; cav ... See more keywords
Cardiac allograft vasculopathy-the enduring enemy of cardiac transplantation.
Sign Up to like & getrecommendations! Published in 2019 at "Transplantation"
DOI: 10.1097/tp.0000000000002704
Abstract: Cardiac allograft vasculopathy remains a major limiting factor in the long-term survival of the heart transplant recipient. Our understanding of its pathogenesis is continuously evolving as advances in imaging modalities have allowed a direct window… read more here.
Keywords: transplantation; allograft vasculopathy; cardiac allograft;
Primary Graft Dysfunction Is Associated With Development of Early Cardiac Allograft Vasculopathy, but Not Other Immune-mediated Complications, After Heart Transplantation.
Sign Up to like & getrecommendations! Published in 2023 at "Transplantation"
DOI: 10.1097/tp.0000000000004551
Abstract: BACKGROUND We investigated associations between primary graft dysfunction (PGD) and development of acute cellular rejection (ACR), de novo donor-specific antibodies (DSAs), and cardiac allograft vasculopathy (CAV) after heart transplantation (HT). METHODS A total of 381… read more here.
Keywords: incidence; development; cardiac allograft; allograft vasculopathy ... See more keywords